Joseph Coleman
Neurology with Special Qualifications in Child Neurology · Oklahoma City, OKNPI 1295230860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by UCB, Inc. at 36.2% of the total.
Across 115 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$891
- Neurelis, Inc.$293
- Jazz Pharmaceuticals Inc.$193
- Immedica Pharma US, Inc.$184
- Catalyst Pharmaceuticals, Inc.$181
- Acadia Pharmaceuticals Inc$178
- plus $544 from 15 others
What the payments were for
- Food & beverage$2,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 42 | $891 |
| Neurelis, Inc. | 13 | $293 |
| Jazz Pharmaceuticals Inc. | 10 | $193 |
| Immedica Pharma US, Inc. | 6 | $184 |
| Catalyst Pharmaceuticals, Inc. | 9 | $181 |
| Acadia Pharmaceuticals Inc | 8 | $178 |
| SK Life Science, Inc. | 5 | $112 |
| Biogen | 4 | $81 |
| Pyros Pharmaceuticals, Inc. | 2 | $58 |
| Upsher-smith Laboratories LLC | 2 | $52 |
| Sumitomo Pharma America, Inc. | 4 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $29 |
| Biomarin Pharmaceutical Inc. | 1 | $24 |
| Intrabio Inc | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
How this compares
Too few neurology with special qualifications in child neurology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Oklahoma City
- Jennifer NormanOklahoma City$13K
- Andrew CeaseOklahoma City$5K
- Brittany PoinsonOklahoma City$3K
- Daniel ArringtonOklahoma City$176
- Candace CurryOklahoma City$95
- Amy StaufferTulsa$4K
- Gabriela PurcarinBethany$837
- David SieglerTulsa$176
- George MillerTulsa$140
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.